Call for contributions to the UN Secretary-General’s High-level Panel on Access to Medicines

Call for contributions to the UN Secretary-General’s High-level Panel on Access to Medicines

The United Nations Secretary-General’s High-Level Panel on Access to Medicines is calling for proposals to enhance and strengthen the promotion of innovation and access to medicines, vaccines and diagnostics.

Read More

UN logo resources sectionThe panel will consider contributions that promote research, development, innovation and increase access to medicines, vaccines, diagnostics and related health technologies. Submissions should also address the misalignment between the rights of inventors, international human rights law, trade rules and public health where it impedes the innovation of and access to health technologies.

In accordance with Sustainable Development Goal 3, and the integrated nature of the 2030 Agenda for Sustainable Development, contributions are not limited to any specific set of countries or any diseases.

Submitted contributions should be:

  • Evidence-informed and include references to the principles, literature and models upon which the contribution is based;
  • Reflect, align and demonstrate how it will support the attainment of the 2030 Agenda for Sustainable Development and in particular, Sustainable Development Goal 3, that aims to improve the health and wellbeing for all, and;
  • Where applicable, indicate the political, financial or other requirements to the implement of the proposed ideas.

While critical to the attainment of health outcomes, broader issues relating to health systems strengthening and supply chain management fall outside of the scope of the panel’s enquiry.

The Secretariat of the High-Level Panel at United Nations Development Programme in collaboration with UNAIDS, and in coordination with the Expert Advisory Group, will short-list contributions against the criteria below:

  • Impact on policy coherence;
  • Public health impact;
  • Ability to describe conditions for implementation; and
  • Evidence base

Submissions should be received by email or mail, by 11 pm, Eastern Standard Time, Thursday 28 February 2016

View the call for more information